US Dollar vs Yen

登録してリアルタイムのチャート、分析ツール、価格を入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
BriaCell Therapeutics Corporation (BCTX)
BriaCell Therapeutics Corporation (BCTX) ニュース

BCTX

BriaCell Therapeutics (BCTX)

BriaCell Therapeutics Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BCTX

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/04/24	21 : 00	GlobeNewswire Inc.	BriaCell Announces Oral and Poster Presentations at ASCO 2024	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/04/10	21 : 00	GlobeNewswire Inc.	BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/04/09	21 : 00	GlobeNewswire Inc.	BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/03/07	22 : 00	GlobeNewswire Inc.	BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/03/06	22 : 00	GlobeNewswire Inc.	BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/02/27	22 : 00	GlobeNewswire Inc.	BriaCell Provides Update on Alleged Illegal Trading of Public Securities	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/02/07	22 : 00	GlobeNewswire Inc.	BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/02/06	22 : 30	GlobeNewswire Inc.	Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/02/01	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/02/01	07 : 24	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/01/31	12 : 48	GlobeNewswire Inc.	BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/01/23	07 : 00	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/01/10	06 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/01/09	01 : 01	Edgar (US Regulatory)	Form SCHEDULE 13G -	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2024/01/04	22 : 45	GlobeNewswire Inc.	BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/12/28	22 : 55	GlobeNewswire Inc.	BriaCell Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/12/21	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/12/20	22 : 40	GlobeNewswire Inc.	BriaCell Reports Unprecedented Preliminary Survival and Clinical Benefit in Antibody-Drug Conjugate (ADC) Refractory Patient Subset	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/12/15	07 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/12/15	07 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/12/06	23 : 31	GlobeNewswire Inc.	BriaCell Highlights Outstanding Topline Survival and Clinical Benefit Data in Advanced Metastatic Breast Cancer at the 2023 SABCS	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/12/06	23 : 00	GlobeNewswire Inc.	BriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/11/30	21 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/11/30	21 : 00	GlobeNewswire Inc.	BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/11/03	21 : 31	GlobeNewswire Inc.	BriaCell Reports Unprecedented Anti-Tumor Activity of its Next Generation Personalized Breast and Prostate Cancer Immunotherapies in Tumor Models at the 2023 SITC Annual Meeting; FDA Greenlights Bria-OTS™ IND	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/10/25	22 : 15	GlobeNewswire Inc.	BriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology Candidate	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/10/20	22 : 15	GlobeNewswire Inc.	October is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative Technology	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/10/18	22 : 00	GlobeNewswire Inc.	BriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/10/11	22 : 10	GlobeNewswire Inc.	BriaCell To Host Virtual Key Opinion Leader Event on Bria-IMT™ Potential in Advanced Metastatic Breast Cancer on October 26, 2023 Featuring Dr. Adam M. Brufsky from University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo Clinic	NASDAQ:BCTX	BriaCell Therapeutics Corporation
2023/10/04	22 : 00	GlobeNewswire Inc.	BriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast Cancer	NASDAQ:BCTX	BriaCell Therapeutics Corporation

Showing the most relevant articles for your search:NASDAQ:BCTX

1 2 3 4 次へ >>

Bank of America

Verizon Communications

US Dollar vs Sterling

US Dollar vs Yen

US Dollar vs Euro

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約